Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.

Vertex Pharmaceuticals Inc. closed 8.54% short of its 52-week high of $519.88, which the company achieved on November 8th.

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

The opioid crisis has claimed the lives of over half a million Americans since the beginning of the epidemic, a process ...

Vertex Pharmaceuticals has been the apple of investors' search engines, but its recent stock dip of 3.3% might have folks ...

The stock's rise snapped a three-day losing streak.

Global pharma and MedTech stocks rebound as U.S. President Donald Trump issues a 90-day pause on reciprocal tariffs for all ...

Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...

Three homers was a recipe for success for the 2024 Nationals, but Friday night the blasts couldn’t halt a 6-4 loss to Arizona, Washington’s fourth straight. The Nationals placed Soroka on the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...